1015610-31-7 Usage
General Description
4-Chloro-5-iodo-1H-pyrrolo[2,3-b]pyridine is a chemical compound with the molecular formula C8H4ClIN2. Its molecular weight is 282.49. This chemical belongs to the class of organic compounds known as pyrrolopyridines, which are polycyclic aromatic compounds containing a pyrrolopyridine moiety, a structural arrangement of pyrrole and pyridine rings fused together. 4-Chloro-5-iodo-1H-pyrrolo[2,3-b]pyridine is relatively less common, but is used in a variety of chemical research due to its unique functional properties. It is often utilized in the manufacture of more complex chemical structures, usually as a building block or intermediate. It is important to handle this chemical with care, as it may have hazard properties in specific conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1015610-31-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,5,6,1 and 0 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1015610-31:
(9*1)+(8*0)+(7*1)+(6*5)+(5*6)+(4*1)+(3*0)+(2*3)+(1*1)=87
87 % 10 = 7
So 1015610-31-7 is a valid CAS Registry Number.
InChI:InChI=1S/C7H4ClIN2/c8-6-4-1-2-10-7(4)11-3-5(6)9/h1-3H,(H,10,11)
1015610-31-7Relevant articles and documents
Compound with pyrrolopyridine structure, preparation method and medical application
-
, (2021/08/06)
The invention discloses a compound with a pyrrolopyridine structure, a preparation method and medical application. The compound with the pyrrolopyridine structure has obvious inhibitory activity on JAK family proteins, and is an effective JAK inhibitor, so that the compound has a prospect of being developed into drugs for inhibiting JAK and further treating diseases.
BICYCLIC HETEROAROMATIC COMPOUNDS
-
, (2015/09/22)
Compounds of the formula I, in which X1, X2, X3, X4, X5, R1, R2, R3, R4, R5 and R6 have the meanings indicated in Claim 1, are kinase inhibitors and can be employed, inter alia, for the treatment of tumours.